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Summary 
 
 A 35-d growth study with a total of 168 
weanling pigs (21 ± 2 d of age) was conducted 
to determine the effects of feeding a probiotic, 
(KE-01) and an antibiotic, Neoterramycin 
(neomycin 140 g/ton, oxytetracycline 140 
g/ton), on nursery pig performance.  Experi-
mental treatments were arranged in a 2 × 2 
factorial with main effects of antibiotic (none 
or neomycin 140g/ton and oxytetracycline 
140g/ton) or probiotic (none or KE-01, 
0.35%).  KE-01 is a probiotic containing a 
novel strain of lactobacillus casei.  A KE-01 
by Neoterramycin interaction was observed 
for ADFI (P<0.05) from d 14 to 35, but no 
other interactions were detected.  From d 0 to 
14, pigs fed diets containing Neoterramycin 
had improved (P<0.01) ADG, ADFI, and F/G 
compared with those of pigs fed diets without 
Neoterramycin.  Pigs fed diets containing KE-
01 had similar growth performance to that of 
pigs fed diets without KE-01.  From d 14 to 
35, pigs fed diets containing Neoterramycin 
had increased ADG compared with that of 
pigs fed diets without Neoterramycin.  The 
ADG of pigs fed diets containing KE-01 did 
not differ from that of pigs fed diets without 
KE-01. There was a tendency for pigs fed KE-
01 to consume less feed, whereas pigs fed 
Neoterramycin ate more (KE-01 × Neoterra-
mycin interaction, P<0.05).  Pigs fed diets 
containing KE-01 tended to have improved 
F/G (P<0.07), compared with that of pigs fed 
diets without KE-01.  Overall, d 0 to 35, pigs 
fed diets containing Neoterramycin had in-
creased ADG and ADFI (P<0.01), compared 
with those of pigs fed diets without Neoterra-
mycin.  In addition, pigs fed diets containing 
KE-01 had similar ADG and ADFI to those of 
pigs fed diets without KE-01.  Pigs fed diets 
containing KE-01 had improved F/G 
(P<0.03), compared with that of pigs fed diets 
without KE-01.  In summary, the probiotic, 
KE-01, did not significantly increase ADG or 
ADFI, but did improve F/G because it slightly 
lowered feed intakes.  Neoterramycin im-
proved ADG, ADFI, and F/G, compared with 
those of diets without Neoterramycin in this 
study.   
 
(Key Words: Antibiotics, Pigs, Probiotic, 
Weanling Pigs.) 
 
Introduction 
 
 Previous experiments at Kansas State Uni-
versity have demonstrated that adding a feed- 
grade antimicrobial (Neoterramycin, Me-
cadox, or Denagard CTC) to the nursery diet 
consistently increases ADG and improves 
F/G.  KE-01 is a novel strain of Lactobacillus 
casei. In an initial field trial, feeding KE-01 
improved weight gain and bacterial detach-
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ment.  An oral dose of KE-01 also has been 
shown to reduce sulfide and ammonia com-
pounds in feces in pigs.  Initial field trials with 
KE-01 look promising, but growth responses 
must be verified in controlled experiments.  
This study was conducted to evaluate the ef-
fectiveness of the probiotic KE-01 to enhance 
nursery pig performance.  
 
Procedures 
  
 A total of 168 weaned pigs (PIC, initially 
13.7 lb and 21 ± 2 d of age) were blocked by 
weight in a 35 day growth study.  Pigs were 
randomly allotted to one of four dietary treat-
ments in a randomized complete block design.  
Each pen contained six pigs per pen, with 
seven replicates (pens) per treatment.  Pigs 
were housed at the Kansas State Swine Re-
search and Teaching Center.  All pens (4 × 5 
ft) contained one stainless steel self-feeder and 
one nipple waterer to allow ad libitum access 
to feed and water.  
  
 Pigs were fed one of four experimental 
diets, arranged in a 2 × 2 factorial consisting 
of antibiotic (none or neomycin, 140 g/ton and 
oxytetracycline, 140 g/ton) or probiotic (none 
or KE-01, 0.35%).  Experimental diets were 
based on corn-soybean meal and were fed in 
meal form for the 35-day trial.  The phase 1 
diet (1.55% lysine) was fed from d 0 to14, and 
phase 2 diet (1.45% lysine) was fed from d 14 
to 35 post-weaning (Table 1).  Diets did not 
contain growth-promoting amounts of zinc 
oxide.  Also, no water antimicrobials were 
administered throughout the trial.  Pigs were 
weighed, and feed disappearance was meas-
ured on d 0, 7, 14, 21, 28, and 35 to determine 
ADG, ADFI, and feed efficiency (F/G).  Data 
were analyzed as a randomized complete-
block design with pen as the experimental unit 
by using the Mixed procedure of SAS. 
 
 
 
 
Results and Discussion 
 
 From d 0 to 14, no interactions were ob-
served (P>0.53); therefore, the treatment main 
effects are presented in Table 2 and the inter-
active means are shown in Table 3.  Pigs fed 
diets containing Neoterramycin had improved 
ADG, ADFI, and F/G (P<0.01), compared 
with those of pigs fed diets without Neoterra-
mycin.  Pigs fed diets with KE-01 had similar 
ADG, ADFI, and F/G (P>0.12) to those of 
pigs fed diets without KE-01.  
 
 From d 14 to 35, a KE-01 by Neoterramy-
cin interaction was detected for ADFI 
(P<0.05).  This was because of a slight reduc-
tion in ADFI in pigs fed KE-01; Neoterramy-
cin increased ADFI.  Pigs fed diets containing 
Neoterramycin had increased ADG and ADFI 
(P<0.01) compared with those of pigs fed di-
ets without Neoterramycin.  Adding KE-01 to 
the diet had no effect on ADG and ADFI 
(P>0.59), but tended (P<0.07) to improve F/G.  
 
 For the overall treatment period (d 0 to 
35), a tendency for an interaction was ob-
served on ADFI (P<0.08).  Pigs fed diets con-
taining Neoterramycin had greater ADG and 
ADFI (P<0.01), compared with those of pigs 
fed diets without Neoterramycin.  Pigs fed di-
ets containing KE-01 had similar ADG and 
ADFI (P>0.45) to those of pigs fed diets with-
out KE-01.  But pigs fed diets containing KE-
01 had improved F/G (P<0.03), compared 
with that of pigs fed diets without KE-01.  
 
 In agreement with many previous trials, 
this study found that feeding diets containing 
an antibiotic such as Neoterramycin to nursery 
pigs resulted in improved growth perform-
ance.  The probiotic, KE-01, did not improve 
ADG or ADFI, but slightly improved F/G. 
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Table 1.  Diet Composition (As-fed Basis)a 
Ingredient, %  Phase 1b Phase 2c 
Corn  48.13 59.99 
Soybean meal, 46.5% CP  29.00 35.01 
Spray-dried whey  15.00 - 
Select menhaden fish meal  3.75 - 
Test ingredient or starchd  1.00 1.00 
Monocalcium phosphate, 21% P  1.15 1.60 
Limestone  0.70 1.10 
Salt  0.30 0.35 
Vitamin premix  0.25 0.25 
Trace mineral premix  0.15 0.15 
L-Lysine HCl  0.30 0.30 
DL-Methionine  0.15 0.13 
L-Threonine  0.13 0.13 
TOTAL  100.00 100.00 
 
Calculated Analysis    
   Lysine, %  1.55 1.45 
   Isoleucine:lysine ratio, %  61 61 
   Leucine:lysine ratio, %  120 120 
   Methionine:lysine ratio, %  33 32 
   Met & Cys:lysine ratio, %  57 58 
   Threonine:lysine ratio, %  65 65 
   Tryptophan:lysine ratio, %  17 18 
   Valine:lysine ratio, %  68 71 
   ME, kcal/lb  1,473         1,478    
   CP, %    21.7 21.4 
   Ca, %  0.90 0.85 
   P, %  0.80 0.75 
  Lysine:calorie ratio, g/mcal  4.78 4.45 
aAll diets fed in meal form. 
bFed from d 0 to 14 post-weaning. 
cFed from d 14 to 35 post-weaning. 
dNeoterramycin (neomycin 140 g/ton and oxytetracycline 140 
g/ton), KE-01 (Lactobacillus casei, 0.30% and 0.35%, phase 1 and 
2, respectively) replaced corn starch to provide additional dietary 
treatments. 
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Table 2.  Main Effects of KE-01 and In-feed Neomycin/Oxytetracycline on Growth Performance of Nursery Pigsa 
 KE-01c          Neoterramycin  P - value 
Item 0 0.35%d  0 140 g/ton SE KE-01 Neoterramycin
KE-1 * 
Neoterramycin 
Pensb 14 14  14 14     
Day 0 to 14          
   ADG, lb 0.63 0.62  0.57 0.68 0.024 0.77 0.01 0.56 
   ADFI, lb 0.73 0.70  0.67 0.75 0.027 0.38 0.01 0.53 
   F/G 1.15 1.12  1.17 1.11 0.018 0.12 0.01 0.98 
Day 14 to 35          
   ADG, lb 1.35 1.35  1.29 1.41 0.024 0.77 0.01 0.11 
   ADFI, lb 1.91 1.89  1.80 1.99 0.034 0.59 0.01 0.05 
   F/G 1.41 1.39  1.40 1.41 0.010 0.07 0.54 0.36 
Day 0 to 35          
  ADG, lb 1.06 1.06  1.00 1.12 0.020 0.94 0.01 0.15 
   ADFI, lb 1.43 1.41  1.35 1.50 0.027 0.45 0.01 0.08 
   F/G 1.35 1.33  1.35 1.33 0.009 0.03 0.15 0.39 
Final Weight, lb 50.81 50.9  48.74 52.97 0.709 0.91 0.01 0.15 
aDiets fed in meal form, with phase 1 fed from d 0 to 14 and phase 2 fed from d 14 to 35. 
bComparison of two diets with, versus two without, KE-01 and two with, versus two without, Neoterramycin. 
cA novel Lactobacillus casei strain. 
dKE-01 fed at 0.30% phase 1 and 0.35% phase 2, respectively.  
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Table 3.  Effect of Probiotic, KE-01, and In-feed Neomycin/Oxytetracyline on Growth Performance of Weanling Pigsa  
      P-value 
Item Control KE-01bc Neoterramycin
KE-01 and 
Neoterramycin SED Treatment
KE-01 
*Neoterramycin
Med vs. 
non-Med 
KE-01 vs. 
No KE-01 
Day 0 to 14          
   ADG, lb 0.57d 0.58d 0.69e 0.67e 0.034 0.01 0.56 0.01 0.77 
   ADFI, lb 0.68d 0.67d 0.77e 0.73de 0.038 0.04 0.53 0.01 0.38 
   F/G 1.19d 1.16de 1.12ef 1.09f 0.025 0.01 0.98 0.01 0.12 
Day 14 to 35          
   ADG, lb 1.26d 1.31d 1.43e 1.40e 0.034 0.01 0.11 0.01 0.77 
   ADFI, lb 1.78d 1.83d 2.04e 1.95e 0.048 0.01 0.05 0.01 0.59 
   F/G 1.41 1.40 1.42 1.39 0.02 0.19 0.36 0.54 0.07 
Day 0 to 35          
   ADG, lb 0.99d 1.02d 1.14e 1.11e 0.029 0.01 0.15 0.01 0.95 
   ADFI, lb 1.34d 1.37d 1.53e 1.46e 0.038 0.01 0.08 0.01 0.45 
   F/G 1.35d 1.34de 1.35d 1.32e 0.013 0.07 0.39 0.15 0.03 
Final weight, lb 48.16d 49.33d 53.46e 52.48e 1.00 0.01 0.15 0.01 0.91 
aDiets fed in meal form, with phase 1 fed from d 0 to 14 and phase 2 fed from d 14 to 35. 
bA novel Lactobacillus casei strain. 
cKE-01 fed at 0.30% phase 1 and 0.35% phase 2, respectively. 
d,e,fMeans having different superscript letters differ P<0.05. 
 
